Is an anti-cancer vaccine on the way?

BioNTech founders: cancer vaccine will appear before 2030

Svetlana Maslova, Hi-tech+

Scientists believe that a cancer vaccine may become widely available within the next decade. The breakthroughs of mRNA vaccines from COVID-19, achieved during the pandemic, helped speed up the process.

According to Ugur Shahin, founder of BioNTech biotech company, a cancer vaccine should become available in the next decade, quotes Science Alert his interview on the BBC. "The anti-cancer vaccine will be based on the breakthroughs achieved by scientists in the development of the COVID—19 vaccine," Shaheen notes.

BioNTech, in partnership with Pfizer, was one of the first to develop an mRNA vaccine against COVID-19. The COVID-19 pandemic has significantly accelerated the development and testing of mRNA technology. Now scientists expect that the new vaccine will teach the body to recognize and attack cancer using mRNA. It is planned that patients after surgery will be injected with personalized vaccines that induce an immune response against cancer cells.

"The T cells will target the remaining tumor cells for their complete destruction," the authors explain.

While scientists are only making assumptions, however, in their opinion, the necessary scientific basis for creating a personalized anti-cancer approach has already been developed.

It is worth noting that last summer BioNTech announced the launch of the second phase of clinical trials of the mRNA vaccine against cancer. Competitor BioNTech company Moderna has also previously announced the launch of research on the technology for the treatment of cancer. In general, the versatility of the mRNA approach makes it potentially effective in the treatment of many diseases — it is already being tested in the treatment of muscular dystrophy, studied against herpes and smallpox.

Portal "Eternal youth" http://vechnayamolodost.ru